Submitted by Anonymous (not verified) on 22 October 2025 - 16:37
Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 34, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 34, Status: Authorised